The Pharmaceutical Research and Manufacturers of America (PhRMA) and the Biotechnology Innovation Organization (BIO) filed suit in the U.S. District Court for the District of Nevada challenging sections of a Nevada state law that they said would violate patent rights and negate trade secret protection for certain diabetes drugs.